<--- Back to Details
First PageDocument Content
Business / Economy / Pharmaceutical industry / S&P/TSX 60 Index / S&P/TSX Composite Index / Valeant Pharmaceuticals / Allergan /  Plc / Teva Pharmaceutical Industries / Actavis / Mylan / KP / Perrigo
Business
Economy
Pharmaceutical industry
S&P/TSX 60 Index
S&P/TSX Composite Index
Valeant Pharmaceuticals
Allergan
Plc
Teva Pharmaceutical Industries
Actavis
Mylan
KP
Perrigo

Microsoft PowerPoint - Kurmann Partners - An Overview on M&A in the Pharmaceutical industry - CPhI pre-Connect October.

Add to Reading List

Source URL: www.kurmannpartners.com

Download Document from Source Website

File Size: 1,33 MB

Share Document on Facebook

Similar Documents

Filing under Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Filing by: Media General, Inc. Subject Company: Media Ge

Filing under Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Filing by: Media General, Inc. Subject Company: Media Ge

DocID: 1rtIs - View Document

Translation October 29, 2015 Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2016 <under Japanese GAAP>

Translation October 29, 2015 Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2016

DocID: 1rpqN - View Document

Thomson Reuters Eikon Success Story

Thomson Reuters Eikon Success Story

DocID: 1rp7s - View Document

Fourth-Quarter and Full Year 2009 Results FOR IMMEDIATE RELEASE Highlights  Growth in consolidated sales and operating segment income of 9.1% and 4.2% for full-year 2009, respectively

Fourth-Quarter and Full Year 2009 Results FOR IMMEDIATE RELEASE Highlights  Growth in consolidated sales and operating segment income of 9.1% and 4.2% for full-year 2009, respectively

DocID: 1rowq - View Document

Microsoft Word - Keryx Biopharmaceuticals Inc. (KERX) - Initial Complaint.docx

Microsoft Word - Keryx Biopharmaceuticals Inc. (KERX) - Initial Complaint.docx

DocID: 1rk3U - View Document